Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph early_phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

2(50.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Other(1)

Detailed Status

Completed1

Withdrawn1

Not yet recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 12 (50.0%)

N/A2 (50.0%)

Trials by Status

completed125%

withdrawn125%

not_yet_recruiting125%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

completedearly_phase_1

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

NCT05705414

not_yet_recruitingearly_phase_1

Clinical Trials (4)

Showing 4 of 4 trials

NCT05705414Early Phase 1

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

Completed

NCT07437053Early Phase 1

Sarcopenia in Chronic Kidney Disease (CKD) Patients

Not Yet Recruiting

NCT03180775Not Applicable

Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity

Unknown

NCT01495871Not Applicable

Amino Acid Supplementation in Recovery From Traumatic Brain Injury

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4